Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Merck & Co., Inc. (MRK) had Stock-Based Compensation of $185.00M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$16.29B |
|
$-4.24B |
|
$4.20B |
|
$12.09B |
|
$19.49B |
|
$-3.20B |
|
$-333.00M |
|
$-3.53B |
|
$-3.34B |
|
$-4.24B |
|
$-4.24B |
|
$-4.24B |
|
$-4.09B |
|
$-3.20B |
|
$-1.69B |
|
2.47B |
|
2.47B |
|
$-1.72 |
|
$-1.72 |
|
| Balance Sheet Financials | |
$35.02B |
|
$25.43B |
|
$93.67B |
|
$128.69B |
|
$26.95B |
|
$46.67B |
|
$55.81B |
|
$82.75B |
|
$45.93B |
|
$-1.40B |
|
$45.93B |
|
2.47B |
|
| Cash Flow Statement Financials | |
$3.92B |
|
$-10.21B |
|
$-2.98B |
|
$14.69B |
|
$5.40B |
|
$-9.29B |
|
|
Stock-Based Compensation |
$185.00M |
$-2.10B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.30 |
|
-- |
|
-- |
|
0.50 |
|
1.07 |
|
74.24% |
|
-19.65% |
|
-19.65% |
|
-- |
|
-21.70% |
|
-26.03% |
|
$2.93B |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.65 |
|
1.33 |
|
67.48 |
|
-9.24% |
|
304.16% |
|
-3.30% |
|
-4.58% |
|
$18.60 |
|
$1.18 |
|
$1.58 |
|